Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BILINYSE:DXCNASDAQ:HQYNASDAQ:MEDP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBILIBilibili$22.62+0.6%$19.30$12.72▼$31.77$9.45B0.916.02 million shs1.59 million shsDXCDXC Technology$16.21+4.0%$15.51$13.44▼$24.83$2.94B1.21.48 million shs600,798 shsHQYHealthEquity$102.87+1.0%$100.09$65.01▼$116.65$8.90B0.49861,619 shs461,440 shsMEDPMedpace$324.56+1.8%$304.15$250.05▼$459.77$9.33B1.47373,881 shs105,956 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBILIBilibili+7.59%+4.80%+19.89%+51.08%+40.06%DXCDXC Technology-4.00%+1.96%-1.39%+10.86%-15.18%HQYHealthEquity+2.29%-2.80%-8.71%+32.64%+23.33%MEDPMedpace-0.81%+1.61%+7.55%+15.03%-20.75%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBILIBilibili2.1699 of 5 stars1.55.00.00.02.01.71.9DXCDXC Technology3.3647 of 5 stars1.93.00.02.01.81.71.9HQYHealthEquity3.5981 of 5 stars3.53.00.00.02.32.51.9MEDPMedpace4.4332 of 5 stars2.12.00.04.62.14.22.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBILIBilibili 3.00Buy$23.292.96% UpsideDXCDXC Technology 1.83Reduce$17.004.87% UpsideHQYHealthEquity 3.00Buy$118.0914.80% UpsideMEDPMedpace 2.21Hold$344.826.24% UpsideCurrent Analyst Ratings BreakdownLatest DXC, HQY, MEDP, and BILI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/8/2025BILIBilibiliSanford C. BernsteinSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$28.007/8/2025HQYHealthEquityRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingStrong-Buy ➝ Strong-Buy$115.00 ➝ $120.006/24/2025MEDPMedpaceBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform ➝ Equal Weight$300.006/5/2025HQYHealthEquityBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$112.00 ➝ $125.006/5/2025HQYHealthEquityDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$98.00 ➝ $115.006/4/2025HQYHealthEquityThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$94.00 ➝ $104.006/4/2025HQYHealthEquityRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$112.00 ➝ $117.006/4/2025HQYHealthEquityJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetMarket Outperform ➝ Market Outperform$110.00 ➝ $117.006/4/2025HQYHealthEquityBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$110.00 ➝ $125.005/22/2025HQYHealthEquityRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$105.00 ➝ $112.005/21/2025BILIBilibiliHsbc Global ResSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBILIBilibili$3.68B2.57$0.49 per share46.21$4.64 per share4.88DXCDXC Technology$12.87B0.23$10.74 per share1.51$19.28 per share0.84HQYHealthEquity$1.20B7.41$4.29 per share23.96$24.40 per share4.22MEDPMedpace$2.11B4.42$14.09 per share23.04$26.56 per share12.22Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBILIBilibili-$184.51M-$0.20N/A50.27N/A-2.15%-2.59%-1.12%8/28/2025 (Estimated)DXCDXC Technology$389M$2.117.684.904.283.02%19.36%4.77%8/6/2025 (Estimated)HQYHealthEquity$96.70M$1.3775.0936.221.579.80%11.01%6.77%9/2/2025 (Estimated)MEDPMedpace$404.39M$13.1024.7823.765.8019.31%54.36%20.81%7/21/2025 (Confirmed)Latest DXC, HQY, MEDP, and BILI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/21/2025Q2 2025MEDPMedpace$3.01N/AN/AN/A$537.70 millionN/A6/3/2025Q1 2026HQYHealthEquity$0.81$0.97+$0.16$0.61$322.25 million$330.80 million5/14/2025Q4 2025DXCDXC Technology$0.76$0.84+$0.08$1.42$3.13 billion$3.17 billion4/21/2025Q1 2025MEDPMedpace$3.06$3.67+$0.61$3.67$528.38 million$558.57 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBILIBilibiliN/AN/AN/AN/AN/ADXCDXC TechnologyN/AN/AN/AN/AN/AHQYHealthEquityN/AN/AN/AN/AN/AMEDPMedpaceN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBILIBilibili0.231.361.36DXCDXC Technology0.861.221.22HQYHealthEquity0.504.064.06MEDPMedpaceN/A0.730.73Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBILIBilibili16.08%DXCDXC Technology96.20%HQYHealthEquity99.55%MEDPMedpace77.98%Insider OwnershipCompanyInsider OwnershipBILIBilibili22.20%DXCDXC Technology0.61%HQYHealthEquity1.50%MEDPMedpace20.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBILIBilibili8,088417.99 million325.19 millionOptionableDXCDXC Technology120,000181.27 million180.16 millionOptionableHQYHealthEquity3,12086.47 million85.18 millionOptionableMEDPMedpace5,90028.74 million22.91 millionOptionableDXC, HQY, MEDP, and BILI HeadlinesRecent News About These CompaniesAllspring Global Investments Holdings LLC Reduces Stock Position in Medpace Holdings, Inc. (NASDAQ:MEDP)July 8 at 3:26 AM | marketbeat.comMedpace Holdings, Inc. (NASDAQ:MEDP) Receives Consensus Recommendation of "Hold" from BrokeragesJuly 6 at 2:31 AM | marketbeat.comMedpace Holdings, Inc. (NASDAQ:MEDP) Receives Average Rating of "Hold" from AnalystsJuly 6 at 2:31 AM | marketbeat.comMEDP - Medpace Holdings Inc Key Metrics | MorningstarJuly 4, 2025 | morningstar.comMHarel Insurance Investments & Financial Services Ltd. Acquires 850 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP)July 4, 2025 | marketbeat.comOGN vs. MEDP: Which Stock Is the Better Value Option?July 3, 2025 | zacks.com11,688 Shares in Medpace Holdings, Inc. (NASDAQ:MEDP) Bought by Tandem Investment Advisors Inc.July 3, 2025 | marketbeat.comComparing Medpace (NASDAQ:MEDP) & Sonic Healthcare (OTCMKTS:SKHHY)July 3, 2025 | americanbankingnews.comMedpace (MEDP) Exceeds Market Returns: Some Facts to ConsiderJuly 2, 2025 | zacks.comSmith Group Asset Management LLC Buys 5,436 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP)July 1, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Has $2.22 Million Stock Position in Medpace Holdings, Inc. (NASDAQ:MEDP)June 29, 2025 | marketbeat.comMEDP - Medpace Holdings Inc Valuation | MorningstarJune 27, 2025 | morningstar.comMMedpace Holdings, Inc. (MEDP) Cash Flow - Yahoo FinanceJune 27, 2025 | finance.yahoo.comMedpace (MEDP) Stock Dips While Market Gains: Key FactsJune 26, 2025 | zacks.comMoran Wealth Management LLC Purchases Shares of 16,928 Medpace Holdings, Inc. (NASDAQ:MEDP)June 26, 2025 | marketbeat.comReflecting On Drug Development Inputs & Services Stocks’ Q1 Earnings: Medpace (NASDAQ:MEDP)June 25, 2025 | msn.comBessemer Group Inc. Purchases 6,225 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP)June 25, 2025 | marketbeat.comBarclays Initiates Coverage of Medpace Holdings (MEDP) with Equal-Weight RecommendationJune 25, 2025 | msn.comMedpace Holdings, Inc. to Report Second Quarter 2025 Financial Results on July 21, 2025 - Business WireJune 24, 2025 | businesswire.comMEDP - Medpace Holdings Inc Trailing Returns | MorningstarJune 24, 2025 | morningstar.comMBarclays Begins Coverage on Medpace (NASDAQ:MEDP)June 24, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDXC, HQY, MEDP, and BILI Company DescriptionsBilibili NASDAQ:BILI$22.62 +0.14 (+0.62%) As of 12:48 PM EasternBilibili Inc. provides online entertainment services for the young generations in the People's Republic of China. It offers a range of digital content, including professional user generated videos, mobile games, and value-added services, such as live broadcasting, occupationally generated videos, audio drama on Maoer, and comics on Bilibili Comic. The company also provides advertising services; and IP derivatives and other services. In addition, it engages in the business and technology development activities; e-commerce business; and video, comics, and game distribution activities. Bilibili Inc. was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.DXC Technology NYSE:DXC$16.21 +0.62 (+3.98%) As of 12:51 PM EasternDXC Technology Company, together with its subsidiaries, provides information technology services and solutions in the United States, the United Kingdom, rest of Europe, Australia, and internationally. It operates in two segments, Global Business Services (GBS) and Global Infrastructure Services (GIS). The GBS segment offers a portfolio of analytics services and extensive partner ecosystem that help its customers to gain insights, automate operations, and accelerate their transformation journeys; and software engineering, consulting, and data analytics solutions, which enable businesses to run and manage their mission-critical functions, transform their operations, and develop new ways of doing business. This segment also simplifies, modernize, and accelerate mission-critical applications that support business agility and growth through applications services; provides proprietary modular insurance software and platforms; and operates a wide spectrum of insurance business process services, as well as helps to operate and improve bank cards, payment and lending process and operations, and customer experiences. The GIS segment offers security services, such as IT security, operations and culture for migrating to the cloud, protecting data with a zero-trust strategy, and manage a security operation center; and cloud infrastructure and IT outsourcing services. This segment also delivers a consumer-like experience, centralize IT management, and support services, as well as improves the total cost of ownership; and orchestrates hybrid cloud and multicloud environments. The company markets and sells its products through direct sales force to commercial businesses and public sector enterprises. DXC Technology Company was founded in 1959 and is headquartered in Ashburn, Virginia.HealthEquity NASDAQ:HQY$102.87 +1.04 (+1.02%) As of 12:48 PM EasternHealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.Medpace NASDAQ:MEDP$324.56 +5.66 (+1.77%) As of 12:48 PM EasternMedpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AST SpaceMobile: Is Market Noise Drowning Out a $100M Signal? CoreWeave's $9 Billion Power Play for Core Scientific Taiwan Semiconductor May Profit from Chinese Manufacturing Issues Micron Insiders Sell But Investors Should Buy, Buy, Buy Believe the Hype? Can SoFi Maintain Its 3-Month Rally? Sizzling Insider Buys for Your High-Yield Watchlist Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
